LeonaBio Free Cash Flow (FCF) History (LONA)

LeonaBio reported −$97.2M in free cash flow for fiscal 2024, an increase of $3.9M from the previous fiscal year.

View full LeonaBio company overview

LeonaBio free cash flow by year

LeonaBio annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20242024-12-31−$97.2M$3.9M
20232023-12-31−$101.1M−$27.4M
20222022-12-31−$73.6M−$28.9M
20212021-12-31−$44.7M−$18.2M
20202020-12-31−$26.4M

LeonaBio free cash flow growth trends

LeonaBio's latest reported quarter, Q4 2024, generated −$26.0M in free cash flow, an increase of $280,000 year over year.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review LeonaBio filings at SEC.gov ↗